Dominari Holdings Inc. — 2019 Q1 Form 10-Q summary
Issuer discrepancy: The supplied filing is for Spherix Incorporated and its subsidiaries (ticker SPEX), not Dominari Holdings Inc. The summary below reflects the filing’s named issuer. Reporting period: three months ended March 31, 2019; financial statements are unaudited.
Business context
Spherix described itself as a technology development company transitioning from intellectual-property monetization toward biotechnology and blockchain initiatives. It held an investment in Hoth Therapeutics and was pursuing a proposed transaction with CBM BioPharma. The CBM transaction was restructured after quarter-end; the filing reports the revised agreement as a subsequent event.
Financial performance and position
| Metric | Q1 2019 / March 31, 2019 | Comparable period / December 31, 2018 |
|---|---|---|
| Revenue | No revenue value reported in the supplied filing text | No clear comparable value provided |
| Operating expenses | $713,000 | $1.577 million |
| Operating loss | $713,000 | $1.577 million |
| Other expense (income), net | $436,000 expense | $91,000 income |
| Net loss | $1.149 million | $1.486 million |
| Net loss per share | $0.57 | $0.96 |
| Operating cash flow | $896,000 used | $1.076 million used |
| Cash and cash equivalents | $446,000 | $22,000 |
| Marketable securities | $1.256 million | $2.700 million |
| Total assets | $11.937 million | $13.251 million |
| Total liabilities | $982,000; no debt balance separately reported | $1.153 million |
Margins cannot be calculated from the supplied filing text because it does not provide a clear revenue figure. Working capital was approximately $0.9 million. The Hoth investment was valued at $8.939 million at March 31, largely based on its quoted market price; the company also reported $1.0 million invested in DatChat and $0.1 million in Mellow Scooters. No cash interest or taxes were paid during the quarter.
Material changes versus Q1 2018
- Operating expenses fell by $864,000, including lower patent amortization, professional fees, acquisition costs, and compensation expenses. Patent amortization was zero versus $338,000 a year earlier.
- Net loss narrowed by $337,000, but other income of $91,000 in Q1 2018 became other expense of $436,000 in Q1 2019, including a $475,000 fair-value loss on investments and a $53,000 increase in warrant liabilities.
- Operating cash use improved by $180,000. Investing activities provided $1.320 million, chiefly from net sales of marketable securities; there was no financing cash flow in Q1 2019, compared with $2.7 million of equity proceeds in Q1 2018.
- Cash rose from $22,000 at year-end to $446,000, while marketable securities declined by $1.444 million.
Outlook, risks, and unusual items
- Going concern: Management reported substantial doubt about the company’s ability to continue as a going concern within one year from the filing date, citing recurring losses, operating cash deficits, and accumulated deficit. It said additional financing may be needed and might not be available on favorable terms or at all.
- CBM agreement after quarter-end: On May 15, 2019, Spherix replaced its proposed merger with an asset-purchase agreement for stated consideration of $8 million: $7 million in stock and $1 million in cash, subject to adjustments. The cash is payable upon a qualifying financing; CBM is entitled to financing proceeds above the first $2 million and to proceeds from subsequent equity financings until the cash amount is satisfied. Closing conditions and a September 30, 2019 outside date apply. The filing describes the transaction as subject to closing conditions; it should not be treated as completed based on this report.
- The filing also describes a May 15 agreement to acquire a 20% CBM interest and certain DatChat securities and rights for $350,000; closing was expected within 10 business days. This was a subsequent event, not a Q1 transaction.
- A one-for-4.25 reverse stock split became effective May 10, 2019. The filing’s share figures and references to the split may warrant reconciliation when comparing share counts.
- Disclosure controls were deemed ineffective at March 31, 2019 due to material weaknesses, including insufficient segregation of duties and inadequate controls to ensure material transactions and developments were reflected in the financial statements.
- The company reported no known pending material legal claims and no pending counterclaims. It disclosed no off-balance-sheet arrangements.
Investor facts to verify
- Confirm the issuer identity: the supplied filing is Spherix Incorporated, whereas the request names Dominari Holdings Inc.
- Review available liquidity, financing needs, and the going-concern disclosure, especially against the post-quarter CBM and DatChat commitments.
- Verify whether the CBM asset acquisition and the separate $350,000 share purchase closed, and determine their final consideration, financing effects, and share dilution.
- Assess the valuation and concentration risk of the Hoth investment and the fair-value accounting effects on reported earnings.
- Review remediation of the disclosed material weaknesses and confirm the share-count presentation following the reverse split.